Tech Company Financing Transactions

Coferon Funding Round

Ascent Biomedical Ventures, Hatteras Venture Partners and MedImmune Ventures invested in a $12 million Series B funding round for Coferon. The funding round closed on 7/17/2012.

Transaction Overview

Company Name
Announced On
7/17/2012
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series B
Investors

Ascent Biomedical Ventures (Lead Investor)

Hatteras Venture Partners (Lead Investor)

MedImmune Ventures (Lead Investor)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Health Sciences Dr.
Stony Brook, NY 11790
USA
Email Address
Overview
Coferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells.
Profile
Coferon LinkedIn Company Profile
Social Media
Coferon Company Twitter Account
Company News
Coferon News
Facebook
Coferon on Facebook
YouTube
Coferon on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Colin Goddard
  Colin Goddard LinkedIn Profile  Colin Goddard Twitter Account  Colin Goddard News  Colin Goddard on Facebook
VP - Bus. Development
Maneesh Pingle
  Maneesh Pingle LinkedIn Profile  Maneesh Pingle Twitter Account  Maneesh Pingle News  Maneesh Pingle on Facebook
VP - R & D
Jutta Wanner
  Jutta Wanner LinkedIn Profile  Jutta Wanner Twitter Account  Jutta Wanner News  Jutta Wanner on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/17/2012: Loggly venture capital transaction
Next: 7/17/2012: Totsy venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary